Kaveri Pohlman is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/27/2024
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/17/2024 | CGEM | Buy Now | Cullinan Oncology | $25.10 | 19.52% | BTIG | Kaveri Pohlman32% | $20 → $30 | Maintains | Buy | Get Alert |
| 04/16/2024 | XNCR | Buy Now | Xencor | $19.98 | 90.19% | BTIG | Kaveri Pohlman32% | $56 → $38 | Maintains | Buy | Get Alert |
| 03/26/2024 | NUVB | Buy Now | Nuvation Bio | $2.75 | 81.82% | BTIG | Kaveri Pohlman32% | → $5 | Upgrade | Neutral → Buy | Get Alert |
| 03/21/2024 | JANX | Buy Now | Janux Therapeutics | $47.39 | 30.83% | BTIG | Kaveri Pohlman32% | → $62 | Initiates | → Buy | Get Alert |
| 03/04/2024 | MGNX | Buy Now | Macrogenics | $14.50 | 65.52% | BTIG | Kaveri Pohlman32% | $12 → $24 | Maintains | Buy | Get Alert |
| 02/09/2024 | PYXS | Buy Now | Pyxis Oncology | $4.30 | 86.05% | BTIG | Kaveri Pohlman32% | → $8 | Initiates | → Buy | Get Alert |
| 12/19/2023 | EXEL | Buy Now | Exelixis | $23.70 | 13.92% | BTIG | Kaveri Pohlman32% | → $27 | Initiates | → Buy | Get Alert |
| 10/13/2023 | GMAB | Buy Now | Genmab | $28.15 | 63.41% | BTIG | Kaveri Pohlman32% | $44 → $46 | Maintains | Buy | Get Alert |
| 09/12/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | BTIG | Kaveri Pohlman32% | → $26 | Initiates | → Buy | Get Alert |
| 08/24/2023 | GMAB | Buy Now | Genmab | $28.15 | 56.31% | BTIG | Kaveri Pohlman32% | → $44 | Initiates | → Buy | Get Alert |
| 08/23/2023 | RCUS | Buy Now | Arcus Biosciences | $15.55 | 350.16% | BTIG | Kaveri Pohlman32% | → $70 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2023 | MGNX | Buy Now | Macrogenics | $14.50 | -17.24% | BTIG | Kaveri Pohlman32% | $6 → $12 | Maintains | Buy | Get Alert |
| 11/21/2022 | CGEM | Buy Now | Cullinan Oncology | $25.10 | -20.32% | BTIG | Kaveri Pohlman32% | → $20 | Initiates | → Buy | Get Alert |
| 11/14/2022 | ONCS | Buy Now | OncoSec Medical | — | — | BTIG | Kaveri Pohlman32% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/31/2022 | STTK | Buy Now | Shattuck Labs | $10.59 | 13.31% | BTIG | Kaveri Pohlman32% | → $12 | Initiates | → Buy | Get Alert |
| 08/02/2022 | NUVB | Buy Now | Nuvation Bio | $2.75 | — | BTIG | Kaveri Pohlman32% | — | Downgrade | Buy → Neutral | Get Alert |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $1.59 | 403.14% | BTIG | Kaveri Pohlman32% | $16 → $8 | Maintains | Buy | Get Alert |
| 06/01/2022 | NEXI | Buy Now | NexImmune | $3.50 | 42.86% | BTIG | Kaveri Pohlman32% | → $125 | Initiates | → Buy | Get Alert |
| 04/20/2022 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | BTIG | Kaveri Pohlman32% | — | Downgrade | Buy → Neutral | Get Alert |
